Literature DB >> 7245395

[Pathophysiology of hemodynamic and metabolic disturbances following circulatory shock (author's transl)].

F R Matthias, H G Lasch.   

Abstract

Circulatory shock is defined as a syndrome of hemodynamic and metabolic disturbances. Impairment of macro- and microcirculation initiated by different causes is followed by a reversible and later on by an irreversible disturbance of cell metabolism. Breakdown of organ function may be the consequence. The shock specific discomposure of the hemostatic system is characterized by an inactivation of blood coagulation. This leads first to hypercoagulability accompanied by a tendency to thrombosis; later on the impairment of the hemostatic balance is followed by the consumption of coagulation factors and by hypocoagulability with a more or less pronounced bleeding tendency. Treatment of shock is the main prerequisite to avoid and overcome shock induced coagulation disorder. Heparin administration, fresh blood and fresh plasma are adjuvant measures. Substitution of concentrates of clotting factors are indicated only in states of total consumption of the coagulation system.

Entities:  

Mesh:

Year:  1981        PMID: 7245395     DOI: 10.1007/bf02589640

Source DB:  PubMed          Journal:  Unfallchirurgie        ISSN: 0340-2649


  13 in total

Review 1.  Local fibrinolysis as a mechanism for haemorrhage.

Authors:  I M Nilsson
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

Review 2.  [Hemostatic defects in shock (author's transl)].

Authors:  D L Heene; F R Matthias
Journal:  Verh Dtsch Ges Pathol       Date:  1978

Review 3.  [Shock-lung (author's transl)].

Authors:  C Mittermayer; U N Riede; U Bleyl; H Herzog; P von Wichert; K Riesner
Journal:  Verh Dtsch Ges Pathol       Date:  1978

4.  [Experiences with heparin treatment of consumption coagulopathy in posttraumatic respiratory insufficiency ("shock lung")].

Authors:  M Schamaun; D Bernhardt; M H Hörder
Journal:  Helv Chir Acta       Date:  1974-03

5.  [Pathogenesis of fat embolism. 2. Modification of post-traumatic hyperlipoproteinemia in experimental drug-induced fat embolism].

Authors:  K Huth; G Blümel; F W Schmahl; K Irsigler
Journal:  Med Welt       Date:  1974-10-18

6.  Coagulation defects associated with massive blood transfusions.

Authors:  R D Miller; T O Robbins; M J Tong; S L Barton
Journal:  Ann Surg       Date:  1971-11       Impact factor: 12.969

7.  The importance of intravascular coagulation and inhibition of the fibrinolytic system in experimental fat embolism.

Authors:  T Saldeen
Journal:  J Trauma       Date:  1970-04

Review 8.  Trends in microvascular research. The microembolism syndrome.

Authors:  T Saldeen
Journal:  Microvasc Res       Date:  1976-03       Impact factor: 3.514

9.  [Pro and con: Consumption coagulopathy--heparin treatment? Arguments against heparin treatment].

Authors:  P W Straub
Journal:  Internist (Berl)       Date:  1980-07       Impact factor: 0.743

10.  Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy ("Verbrauchskoagulopathie").

Authors:  H G Lasch; D L Heene; K Huth; W Sandritter
Journal:  Am J Cardiol       Date:  1967-09       Impact factor: 2.778

View more
  1 in total

1.  [Risk of lung embolism following preventive intravenous use of heparin in polytraumatized patients].

Authors:  U Bosch; H Reilmann; J Sturm; W J Kleemann; G Windus
Journal:  Langenbecks Arch Chir       Date:  1988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.